FDA Drug Recalls

Recalls / Class III

Class IIID-1208-2019

Product

Clindamycin Phosphate Topical Solution USP, 1% (10 mg/mL clindamycin), 60 pledget applicators per jar, Rx only. Manufactured by Ei LLC 2865 N. Cannon Blvd. Kannapolis, NC 18083. NDC# 61748-0201-60

Affected lot / code info
Lot# 2530200, Expiration date: 1/31/2019. Lot# 2530300, Expiration date: 1/31/2019. Lot# 2530400, Expiration date: 1/31/2019. Lot# 2607300, Expiration date: 1/31/2019. Lot# 2607400, Expiration date: 1/31/2019. Lot# 2607500, Expiration date: 1/31/2019. Lot# 2607600, Expiration date: 1/31/2019. Lot# 2615800, Expiration date: 1/31/2019. Lot# 2630200, Expiration date: 2/28/2019. Lot# 2630300, Expiration date: 2/28/2019.

Why it was recalled

Failed Impurities/Degradation Specifications; out of specification results observed for other individual impurities

Recalling firm

Firm
Akorn, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1222 W Grand Ave, N/A, Decatur, Illinois 62522-1412

Distribution

Quantity
58,393 jars
Distribution pattern
Nationwide USA and Puerto Rico

Timeline

Recall initiated
2018-10-29
FDA classified
2019-04-23
Posted by FDA
2018-12-05
Terminated
2022-08-09
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1208-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.